85 related articles for article (PubMed ID: 24828671)
1. Coexistence of three variants involving two different fusion partners of ROS1 including a novel variant of ROS1 fusions in lung adenocarcinoma: a case report.
Cai W; Li W; Ren S; Zheng L; Li X; Zhou C
J Thorac Oncol; 2014 Jun; 9(6):e43-6. PubMed ID: 24828671
[No Abstract] [Full Text] [Related]
2. [A new target in non-small cell lung cancer: ROS1 fusion gene].
Cai WJ; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):1-4. PubMed ID: 23648291
[No Abstract] [Full Text] [Related]
3. Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.
Chen YF; Hsieh MS; Wu SG; Chang YL; Shih JY; Liu YN; Tsai MF; Tsai TH; Yu CJ; Yang JC; Yang PC
J Thorac Oncol; 2014 Aug; 9(8):1171-9. PubMed ID: 25157770
[TBL] [Abstract][Full Text] [Related]
4. CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma.
Matsuura S; Shinmura K; Kamo T; Igarashi H; Maruyama K; Tajima M; Ogawa H; Tanahashi M; Niwa H; Funai K; Kohno T; Suda T; Sugimura H
Oncol Rep; 2013 Oct; 30(4):1675-80. PubMed ID: 23877438
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Crizotinib among Different Types of ROS1 Fusion Partners in Patients with ROS1-Rearranged Non-Small Cell Lung Cancer.
Li Z; Shen L; Ding D; Huang J; Zhang J; Chen Z; Lu S
J Thorac Oncol; 2018 Jul; 13(7):987-995. PubMed ID: 29704675
[TBL] [Abstract][Full Text] [Related]
6. CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations.
Li W; Fei K; Guo L; Wang Y; Shu C; Wang J; Ying J
J Thorac Oncol; 2024 Apr; 19(4):613-625. PubMed ID: 38070598
[TBL] [Abstract][Full Text] [Related]
7. Mouse models for ROS1-fusion-positive lung cancers and their application to the analysis of multikinase inhibitor efficiency.
Inoue M; Toki H; Matsui J; Togashi Y; Dobashi A; Fukumura R; Gondo Y; Minowa O; Tanaka N; Mori S; Takeuchi K; Noda T
Carcinogenesis; 2016 May; 37(5):452-60. PubMed ID: 26964870
[TBL] [Abstract][Full Text] [Related]
8. Miliary brain metastases in a patient with ROS1-rearranged lung adenocarcinoma: a case report.
Dziadziuszko K; Szurowska E; Pienkowska J; Jassem J; Dziadziuszko R
J Thorac Oncol; 2014 May; 9(5):e34-6. PubMed ID: 24722162
[No Abstract] [Full Text] [Related]
9. Identifying and targeting ROS1 gene fusions in non-small cell lung cancer.
Davies KD; Le AT; Theodoro MF; Skokan MC; Aisner DL; Berge EM; Terracciano LM; Cappuzzo F; Incarbone M; Roncalli M; Alloisio M; Santoro A; Camidge DR; Varella-Garcia M; Doebele RC
Clin Cancer Res; 2012 Sep; 18(17):4570-9. PubMed ID: 22919003
[TBL] [Abstract][Full Text] [Related]
10. [Crizotinib Treatment Combined with Resection and Whole-brain Radiation Therapy
in A ROS1 Rearranged Lung Adenocarcinoma with Brain Metastasis:
Case Report and Literature Review].
Zhang M; Nie L; Zhang J
Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):525-9. PubMed ID: 27561802
[TBL] [Abstract][Full Text] [Related]
11. ROS kinase fusions are not common in Chinese patients with cholangiocarcinoma.
Liu P; Wu Y; Sun L; Zuo Q; Shi M
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):474-8. PubMed ID: 23644102
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid Tumors.
Heydt C; Ruesseler V; Pappesch R; Wagener S; Haak A; Siebolts U; Riedel R; Michels S; Wolf J; Schultheis AM; Rehker J; Buettner R; Merkelbach-Bruse S
J Mol Diagn; 2019 Nov; 21(6):971-984. PubMed ID: 31382035
[TBL] [Abstract][Full Text] [Related]
13. Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins.
Neel DS; Allegakoen DV; Olivas V; Mayekar MK; Hemmati G; Chatterjee N; Blakely CM; McCoach CE; Rotow JK; Le A; Karachaliou N; Rosell R; Riess JW; Nichols R; Doebele RC; Bivona TG
Cancer Res; 2019 Feb; 79(3):546-556. PubMed ID: 30538120
[TBL] [Abstract][Full Text] [Related]
14. Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort.
Mazières J; Zalcman G; Crinò L; Biondani P; Barlesi F; Filleron T; Dingemans AM; Léna H; Monnet I; Rothschild SI; Cappuzzo F; Besse B; Thiberville L; Rouvière D; Dziadziuszko R; Smit EF; Wolf J; Spirig C; Pecuchet N; Leenders F; Heuckmann JM; Diebold J; Milia JD; Thomas RK; Gautschi O
J Clin Oncol; 2015 Mar; 33(9):992-9. PubMed ID: 25667280
[TBL] [Abstract][Full Text] [Related]
15. Development of lung adenocarcinomas with exclusive dependence on oncogene fusions.
Saito M; Shimada Y; Shiraishi K; Sakamoto H; Tsuta K; Totsuka H; Chiku S; Ichikawa H; Kato M; Watanabe S; Yoshida T; Yokota J; Kohno T
Cancer Res; 2015 Jun; 75(11):2264-71. PubMed ID: 25855381
[TBL] [Abstract][Full Text] [Related]
16. Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report.
Dong L; Xia J; Zhang J; Zhang Y; Zhu N; Zhang P; Zhang Y; Zhang X; Li S
BMC Pulm Med; 2018 Jan; 18(1):13. PubMed ID: 29361925
[TBL] [Abstract][Full Text] [Related]
17. Identification of ROS1 rearrangement in gastric adenocarcinoma.
Lee J; Lee SE; Kang SY; Do IG; Lee S; Ha SY; Cho J; Kang WK; Jang J; Ou SH; Kim KM
Cancer; 2013 May; 119(9):1627-35. PubMed ID: 23400546
[TBL] [Abstract][Full Text] [Related]
18. Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series.
Chiari R; Buttitta F; Iacono D; Bennati C; Metro G; Di Lorito A; Iezzi M; Tiseo M; Mazzoni F; Cappuzzo F; Marchetti A; Crinò L
Clin Lung Cancer; 2014 Nov; 15(6):470-4. PubMed ID: 25087901
[No Abstract] [Full Text] [Related]
19. [Detection of ROS1 fusion gene in pulmonary adenocarcinoma and its clinicopathologic features].
Liu J; Zhao R; Teng H; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2015 Jun; 44(6):390-4. PubMed ID: 26704833
[TBL] [Abstract][Full Text] [Related]
20. ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases.
Yoshida A; Kohno T; Tsuta K; Wakai S; Arai Y; Shimada Y; Asamura H; Furuta K; Shibata T; Tsuda H
Am J Surg Pathol; 2013 Apr; 37(4):554-62. PubMed ID: 23426121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
